Background: As access to and duration of antiretroviral therapy (ART) increase, the number of patients experiencing first-line ART failure, followed by the need for second-line treatment is rising. The availability of second-line ART drugs is, however, often insufficient in resource-limited settings. For this reason many patients remain on a failing first-line regimen instead of being given more efficient second-line treatment. The long-term consequences and outcomes of this practice in rural areas are uncertain. In rural Tanzania, we have therefore studied the clinical and immunological development of adults and adolescents after virological failure, both those remaining on first-line-, and those being switched to second-line ART. Methods...
Abstract: Scaling up of Antiretroviral (ARV) drugs is crucial and should be a perpetual venture in d...
Background: Risk factors for treatment failure in HIV positive adults have not been studied extensiv...
Objective: This study aims to describe the virological, immunological and clinical efficacy of prote...
BACKGROUND:Virological response to antiretroviral treatment (ART) in rural Africa is poorly describe...
Background: Virological response to antiretroviral treatment (ART) in rural Africa is poorly describ...
Background Virological response to antiretroviral treatment (ART) in rural Africa is...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
INTRODUCTION:The 2016 WHO consolidated guidelines on the use of antiretroviral drugs defines HIV vir...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
Background: Guidelines for the treatment of HIV recommend the use of immunological and clinical crit...
This study aims to describe the virological, immunological and clinical efficacy of protease inhibit...
OBJECTIVES: Rates of first-line treatment failure and switches to second-line therapy are key indica...
Abstract: Scaling up of Antiretroviral (ARV) drugs is crucial and should be a perpetual venture in d...
Background: Risk factors for treatment failure in HIV positive adults have not been studied extensiv...
Objective: This study aims to describe the virological, immunological and clinical efficacy of prote...
BACKGROUND:Virological response to antiretroviral treatment (ART) in rural Africa is poorly describe...
Background: Virological response to antiretroviral treatment (ART) in rural Africa is poorly describ...
Background Virological response to antiretroviral treatment (ART) in rural Africa is...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
INTRODUCTION:The 2016 WHO consolidated guidelines on the use of antiretroviral drugs defines HIV vir...
Background: Currently, there is limited evidence on the effectiveness of second-lin...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
BACKGROUND: An increasing number of people on antiretroviral therapy (ART) in sub-Saharan Africa has...
Background: Guidelines for the treatment of HIV recommend the use of immunological and clinical crit...
This study aims to describe the virological, immunological and clinical efficacy of protease inhibit...
OBJECTIVES: Rates of first-line treatment failure and switches to second-line therapy are key indica...
Abstract: Scaling up of Antiretroviral (ARV) drugs is crucial and should be a perpetual venture in d...
Background: Risk factors for treatment failure in HIV positive adults have not been studied extensiv...
Objective: This study aims to describe the virological, immunological and clinical efficacy of prote...